key: cord-0870490-vq2zm4ig authors: Elmas, Ömer Faruk; Demirbaş, Abdullah; Özyurt, Kemal; Atasoy, Mustafa; Türsen, Ümit title: Cutaneous manifestations of COVID‐19: A review of the published literature date: 2020-05-26 journal: Dermatol Ther DOI: 10.1111/dth.13696 sha: 950e7dfd797b204363e33f0284b5830f498e069c doc_id: 870490 cord_uid: vq2zm4ig COVID‐19 is a highly contagious respiratory tract infection caused by severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2). COVID‐19 outbreak, which caused thousands of deaths, has been declared a pandemic by the World Health Organization in March 2020. The infection has been reported to demonstrate different types of cutaneous manifestations including urticarial, maculopapular, papulovesicular, purpuric, livedoid, and thromboticischemic lesions. Given the high mortality rate of the infection, timely and accurate identification of relevant cutaneous manifestations may play a key role in the early diagnosis and management. In this study, we provide a review with a focus on the reported cutaneous manifestations of COVID‐19. This article is protected by copyright. All rights reserved. COVID-19 is a highly contagious respiratory tract disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), which was first reported on December 1, 2019, from Wuhan, China. 1 . COVID-19 outbreak has been declared a pandemic by the World Health Organization on March 11, 2020 , and as of April 26, 2020 , approximately 3 million cases were identified worldwide and more than 200 thousand deaths occurred. 1,2 SARS-CoV-2 is transmitted through virus-containing droplets and contaminated objects. The incubation period of the infection is ranging between 2 and 14 days, with an average of 5 days 3 . Fever, cough, sore throat, shortness of breath, muscle pain, nausea, diarrhea, and loss of taste and smell have been reported as common symptoms of COVID-19 4 . In addition, organ dysfunction, progressive respiratory failure, and coagulation disorders, which are associated with high mortality, are also reported 5 . Infectious diseases that have serious effects on public health may primarily or secondarily involve the skin. Therefore, timely and accurate identification of skin lesions in patients with fever and rash may significantly increase diagnostic accuracy. Viral infections are common both in children and adults and may cause a wide variety of mucocutaneous manifestations. In the current literature, COVID-19 has also been reported to demonstrate different types of cutaneous manifestations including urticarial, maculopapular, varicella-like, purpuric, livedoid, and thrombotic-ischemic rashes. In this study, we aimed to review the cutaneous findings that have been associated with COVID 19. Infections are one of the common causes of urticaria. and three of these showed urticarial lesions. The lesions predominantly distributed over the trunk, and the urticarial eruption was not related to disease severity. 8 Hedou et al. observed urticarial eruption in two out of 103 patients with COVID-19. In one of these patients, the eruption occurred in the prodromal stage of the infection. 9 Henry et al identified urticarial lesions limited to the face and acral regions in a 27-year-old COVID-19 positive female patient who did not have a high fever 10 . In contrast, C van Damme et al reported two patients with widespread urticarial lesions with fever as the initial signs of COVID- 19. 11 It is obvious that urticaria may be a cutaneous manifestation of a viral infection. In this context, during the pandemic, patients with urticarial lesions should be carefully evaluated for the possibility of COVID 19. Maculopapular eruption is a common cutaneous condition that can be caused by drugs, and bacterial and viral infections. It is often associated with a viral or bacterial infection when accompanied by symptoms such as fever, headache, muscle pain, and respiratory distress. Infectious mononucleosis, measles, scarlet fever, hand-foot-mouth disease, herpes, hepatitis B, hepatitis C, Zika virus, Ebola, and HIV are viral conditions that can cause maculopapular eruptions. 12 Casas Galvan et al 7 reported that 47 percent of 375 patients with COVID-19 had a maculopapular eruption. Some of them showed perifollicular distribution and scaling while some were similar to pityriasis rosea. The authors also reported that a few cases showed infiltrated papular lesions, resembling erythema elevatum diutinum or erythema multiforme. In addition to the primary cutaneous diseases and drug eruptions, many bacterial Livedo reticularis is a cutaneous finding consisting of a mottled reticulated vascular pattern that appears as a lace-like purplish discoloration. It can be associated with progressive ischemia with or without any evidence of systemic diseases. The color change is caused by a decrease in the blood flow of the arterioles feeding the cutaneous capillaries, resulting in blue discoloration due to deoxygenated blood. Systemic diseases-related livedo reticularis is defined as secondary livedo reticularis. Hematological, rheumatic, and cardiovascular diseases and infections can cause secondary livedo reticularis 23 This article is protected by copyright. All rights reserved. Belgium Single case report -A 23-year-old male patient with acute-onset violaceous plaques on the toes and lateral feet. -The lesions appeared three days after a low-grade fever and cough. -The patient had a history of psoriasis, which was treated with secukinumab, however, the secukinumab was stopped one month ago Naming the coronavirus disease (covid-19) and the virus that causes it The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan The COVID-19 epidemic The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients A Review of Coronavirus Disease-2019 (COVID-19) Urticaria and infections Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases Cutaneous manifestations in COVID-19: a first perspective Cutaneous manifestations in COVID-19: a first perspective " by Recalcati S Urticarial eruption in COVID-19 infection Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection Febrile Illness with Skin Rashes A distinctive skin rash associated with Coronavirus Disease A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom. Clin Pract Cases Emerg Med Cutaneous manifestations in COVID-19: a new contribution A case of COVID-19 presenting in clinical picture resembling chilblains disease. First report from the Middle East Cutaneous lesions in a patient with COVID-19: are they related? COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome COVID-19 can present with a rash and be mistaken for Dengue": Petechial rash in a patient with COVID-19 infection Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases Livedo reticularis: A review of the literature Cytomegalovirus (CMV)-related cutaneous necrotizing vasculitis: case report and literature review A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis Clinical recognition of meningococcal disease in children and adolescents Suboptimal care in the initial management of children who died from severe bacterial infection: a population-based confidential inquiry Acute acro-ischemia in the child at the time of COVID-19 COVID-19) infection-induced chilblains: a case report with histopathological findings